IBN (InvestorBrandNetwork) Announces Latest Episode of The Stock2Me Podcast featuring Two-Time Olympic Gold Medalist Abby Wambach on Behalf of Odyssey Health Inc.
July 13, 2022 08:17 ET
|
InvestorBrandNetwork (IBN)
LOS ANGELES, July 13, 2022 (GLOBE NEWSWIRE) -- via InvestorWire – IBN (InvestorBrandNetwork), a multifaceted communications organization engaged in connecting public companies to the investment...
Odyssey Group International Files Patent On Novel Breath-Propelled Nasal Delivery Device
October 19, 2021 10:03 ET
|
Odyssey Group International
IRVINE, CA, Oct. 19, 2021 (GLOBE NEWSWIRE) -- Odyssey Group International, Inc. (OTC:ODYY) (the "Company" or "Odyssey"), a medical technology company focused on developing unique, life-saving...
Odyssey Group International Begins Enrolling Subjects for Phase 1 Clinical Trial to Treat Concussion
September 22, 2021 08:39 ET
|
Odyssey Group International
IRVINE, CA, Sept. 22, 2021 (GLOBE NEWSWIRE) -- Odyssey Group International, Inc. (OTC:ODYY) (the "Company" or "Odyssey"), a medical company focused on developing unique, life-saving medical...
Odyssey Group International to Present at the HC Wainwright 23rd Annual Global Investment Conference
September 09, 2021 08:00 ET
|
Odyssey Group International
IRVINE, CA, Sept. 09, 2021 (GLOBE NEWSWIRE) -- Odyssey Group International, Inc. (OTC: ODYY) (the "Company" or "Odyssey"), a health related company focused on developing unique, medical products...
Odyssey Group International Approved to Start Human Trial to Treat Concussion
September 01, 2021 08:30 ET
|
Odyssey Group International
IRVINE, CA, Sept. 01, 2021 (GLOBE NEWSWIRE) -- Odyssey Group International, Inc. (OTC:ODYY) (the "Company" or "Odyssey"), a company focused on developing unique, life-saving medical products, today...
Odyssey Group International Completes Final Drug-Device Combination Product in Preparation for Clinical Trial Launch
August 30, 2021 08:00 ET
|
Odyssey Group International
IRVINE, CA, Aug. 30, 2021 (GLOBE NEWSWIRE) -- Odyssey Group International, Inc. (OTC:ODYY) (the "Company" or "Odyssey"), a technology and asset acquisition company focused on developing unique...
Odyssey Group International and Super Bowl MVPs Featured on “Banfield” Discussed Novel Concussion Treatment
August 06, 2021 08:30 ET
|
Odyssey Group International
IRVINE, CA, Aug. 06, 2021 (GLOBE NEWSWIRE) -- Odyssey Group International, Inc. (OTC:ODYY) (the "Company" or "Odyssey"), a health related company focused on developing unique, medical products...
Odyssey Group International Completes IND-enabling Studies, Submits Investigator’s Brochure for Phase 1 Clinical Trial
August 04, 2021 09:25 ET
|
Odyssey Group International
IRVINE, CA, Aug. 04, 2021 (GLOBE NEWSWIRE) -- Odyssey Group International, Inc. (OTC:ODYY) (the "Company" or "Odyssey"), a technology and asset acquisition company focused on developing unique,...
The Odyssey Group International Sports Advisory Board Including Three Super Bowl MVPs will Appear on “Banfield” to Discuss Concussion Treatments
July 27, 2021 08:30 ET
|
Odyssey Group International
IRVINE, CA, July 27, 2021 (GLOBE NEWSWIRE) -- Odyssey Group International, Inc. (OTCQB:ODYY) (the "Company" or "Odyssey"), a technology and asset acquisition company focused on developing unique,...
Odyssey Group International, Inc. Provides Notice of Annual Meeting of Stockholders
July 26, 2021 08:32 ET
|
Odyssey Group International
IRVINE, CA, July 26, 2021 (GLOBE NEWSWIRE) -- Odyssey Group International, Inc. (OTCQB: ODYY) ("ODYY" or "the Company"), Odyssey Group International, Inc. (OTCQB:ODYY) (the "Company" or "Odyssey"),...